Display options
Share it on

Biomark Med. 2021 Aug;15(11):841-850. doi: 10.2217/bmm-2020-0514. Epub 2021 Jul 21.

Ceruloplasmin expression in renal cell carcinoma correlates with higher-grade and shortened survival.

Biomarkers in medicine

Annette Zimpfer, Änne Glass, Manuela Bastian, Peter Schuff-Werner, Oliver W Hakenberg, Matthias Maruschke

Affiliations

  1. Institute of Pathology, University Medicine Rostock, Strempelstr 14, Rostock, 18055, Germany.
  2. Institute for Biostatistics & Informatics in Medicine, University Medicine Rostock, Ernst-Heydemann-Str 8, Rostock, 18057, Germany.
  3. Institute of Clinical Chemistry & Laboratory Medicine, University Medicine Rostock, Ernst-Heydemann-Straße 6, Rostock,18057, Germany.
  4. Department of Urology, University Medicine Rostock, Ernst-Heydemann-Str 8, Rostock, 18057, Germany.
  5. Department of Urology, HELIOS Hanseklinikum Stralsund, Große Parower Str 47-53, Stralsund, 18435, Germany.

PMID: 34284640 DOI: 10.2217/bmm-2020-0514

[No abstract available.]

Keywords: biofluid analysis; ceruloplasmin; prognosis; renal cell carcinoma; serum biomarker; tissue biomarker; urine biomarker

Publication Types